News & Announcements
Additional Optiflow European Data published in Journal of Vascular Access
October, 2011
Clinical data for the Optiflow anastomotic connector was accepted for presentation at the Controversies in Dialysis Access (CiDA 2011) conference. The abstract was also published in the July–September issue of the Journal of Vascular Access. » Read More
Optiflow™ European Data Presented at Hungary Vascular Symposium and ASDIN
February, 2011
Clinical data was presented at the Symposium on Vascular Innovations 2010 in Hungary by Dr. Lajos Mátyás and at the ASDIN 2011 meeting by Dr. Prabir Roy-Chaudhury. » Read More
Ben Franklin group announces $2M in early-stage grants
Philadelphia Business Journa • February 14, 2011 11:26 AM EST
Ben Franklin Technology Partners of Southeastern Pennsylvania's board of directors has given it the go-ahead to invest $1.975 million in seven early-stage companies.
Bioconnect Systems Inc. was approved for the largest investment, $500,000. The Malvern, Pa., company's initial products are designed to improve vascular access in hemodialysis patients. » Read More
First optiflow anastomotic connector cases performed in the UK
Vascular News INTERNATIONAL, Issue 49 • January 2011
A team from St George's Hospital, London, UK, led by Eric Chemla, consultant renal transplant and vascular surgeon, chair of the Division of Medicine and Cardiovascular Sciences Renal Transplantation, performed the first four UK cases with the Optiflow anastomotic connector (Bioconnect Systems)
The device replaces handsewn suturing for arteriovenous fistula creation. All patients were treated with the Optiflow, which recently received CE mark approval. » Read More
Bioconnect Systems Gains CE Mark Approval for Optiflow Anastomotic System
Business Wire • September 21, 2010 08:10 AM EST
Innovative Surgical Implant Enhances Surgeon's Ability to Create Arteriovenous Fistulae for Dialysis Access
Bioconnect Systems, Inc. today announced CE mark approval for the Optiflow™ Vascular Anastomotic System. The Optiflow™ enhances a surgeon's ability to create precise vascular connections. The initial indication is the creation of an arteriovenous fistula needed for vascular access in hemodialysis patients. » Read More
Bioconnect Systems to Present First in Man Results for Optiflow™ Vascular Implant
Business Wire • October 27, 2009 07:48 AM EST
Data to be presented at American Society of Nephrology by Prabir Roy-Chaudhury, MD, PhD
Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect's implant platform, the Optiflow™, enhances a surgeon's ability to create precise vascular connections. The initial indication is the creation of an arteriovenous fistula needed for vascular access in dialysis patients. » Read More
Bioconnect Systems Completes $8M Series A Financing
Business Wire • April 05, 2007 02:25 PM EST
New Financing Led by Cardinal & Fidelity Biosciences Funds
Bioconnect Systems, Inc. announced today that the company has raised $8 million in Series A financing. Bioconnect's initial product platform, the Optiflow™, enables surgeons to create precisely controlled connections throughout the body. » Read More